Private equity firm invests in medical comms

Private equity firm NorthEdge has invested in Helios Medical Communications to support an expansion programme by the Cheshire-based agency.

Andrew Minnock, co-founder and managing director of Helios Medical Communications
Andrew Minnock, co-founder and managing director of Helios Medical Communications

Helios is working with NorthEdge to launch a new central Manchester office soon, and assess options for future international expansion.

Ranked 17th on the 2020 Sunday Times FastTrack 100, Helios includes global pharma firms among its clients.

The agency, which was founded by ex-Ashfield Healthcare Communications staffers Andrew Minnock, Emma Bryant and Simon Whiteley in 2015, currently has offices in Cheshire and Oxfordshire.

It has grown significantly in recent years – the headcount rising threefold between 2017, when it had 20 staff, and 2019, when the agency employed 60 people.

Its latest accounts, for the year to 31 December 2019, show it had £5m in net assets.

Commenting on the investment, Andrew Minnock, managing director of Helios, said: “Despite some of the broader challenges in 2020, we’ve enjoyed another excellent year. The business continues to go from strength to strength and that is all down to the people and expertise that we have in our growing team.”

He added: “NorthEdge recognised the importance of the positive culture we have developed, which makes it the ideal partner to support our next phase of growth.” 

As part of the deal, two NorthEdge executives – Grant Berry, managing partner, and Phil Frame, director and head of North West – will become directors of Helios.

Frame described Helios as “a fantastic business based on expertise, passion and a strong team culture”.

He said: “Its focus on investing in people and a commitment to delivering outstanding, high-quality service has enabled Helios to build an excellent reputation with its growing client base.”

Frame commented: “They continue to enjoy strong demand for their services and we look forward to partnering with the team over the coming years to capitalise on the opportunities for growth.”

Click here to subscribe to the FREE pharma and healthcare comms bulletin to receive dedicated healthcare news, features and comment straight to your inbox.

Make sure you register for the site to access more than one story per month.

To submit a news, comment, case study or analysis idea for the pharma and healthcare comms bulletin, email

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in